ADIPOQ and atherosclerosis: Based on these findings, the adiponectin gene variant, or a mutation in linkage with it, determines lower levels of adiponectin protein expression, which in turn increases the risk of developing insulin resistance, atherosclerosis, and cardiovascular disease.